# Commission Regulation (EC) No 1356/2005 of 18 August 2005 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards oxolinic acid and morantel (Text with EEA relevance), Division 1.2.3: Quinolones

Extent: E+W+S+N.I.

Not for use in animals from which milk or eggs are produced for human consumption; MRLs for fat, liver and kidney do not apply to fin fish
For fin fish this MRL relates to ‘muscle and skin in natural proportions’;
For porcine and poultry species this MRL relates to ‘skin and fat in natural proportions’.
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Oxolinic acid
Oxolinic acid
All food-producing species
100 μg/kg
Muscle
50 μg/kg
Fat
150 μg/kg
Liver
150 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2005/1356/annex/division/A/division/1/division/1.2/division/1.2.3 (the official version)
Page: https://openlegislation.uk/eu-regulation-2005-1356/annex/division-A/division-1/division-1.2/division-1.2.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.